Company record
"Daniel C. Tarquinio, D.O./Center for Rare Neurological Diseases
1 FDA warning letter since 2023 and 0 recalls in the last 12 months.
Get an email the day FDA posts anything new about "Daniel C. Tarquinio, D.O./Center for Rare Neurological Diseases.
Warning letters
-
Drugs"Daniel C. Tarquinio, D.O./Center for Rare Neurological Diseases
FDA warns clinical investigator Daniel C. Tarquinio over enrolling ineligible subjects in investigational drug trials.
High risk